Success Metrics

Clinical Success Rate
90.1%

Based on 136 completed trials

Completion Rate
90%(136/151)
Active Trials
80(25%)
Results Posted
7%(9 trials)
Terminated
15(5%)

Phase Distribution

Ph phase_3
1
0%
Ph early_phase_1
1
0%
Ph phase_1
1
0%
Ph phase_2
1
0%
Ph not_applicable
7
2%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
1(9.1%)
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
7(63.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.0%

136 of 160 finished

Non-Completion Rate

15.0%

24 ended early

Currently Active

80

trials recruiting

Total Trials

314

all time

Status Distribution
Active(95)
Completed(136)
Terminated(24)
Other(59)

Detailed Status

Completed136
unknown58
Recruiting56
Active, not recruiting24
Terminated15
Not yet recruiting11

Development Timeline

Analytics

Development Status

Total Trials
314
Active
80
Success Rate
90.1%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (9.1%)
Phase 11 (9.1%)
Phase 21 (9.1%)
Phase 31 (9.1%)
N/A7 (63.6%)

Trials by Status

active_not_recruiting248%
not_yet_recruiting114%
suspended10%
recruiting5618%
completed13643%
terminated155%
enrolling_by_invitation41%
withdrawn93%
unknown5818%

Recent Activity

Clinical Trials (314)

Showing 20 of 314 trialsScroll for more
NCT04860336

Glycemic Observation and Metabolic Outcomes in Mothers and Offspring

Completed
NCT01665326

Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

Recruiting
NCT07270861

Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study

Recruiting
NCT04561193

Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19)

Completed
NCT04700202

Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit

Completed
NCT07485673

GENESIS Project: Generating Evidence on the Needs of Ecuadorian Adolescents

Recruiting
NCT05002621

Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma

Completed
NCT03021031

Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Clinical Core

Enrolling By Invitation
NCT06857630

Preoperative Hemoglobin and Acute Kidney Injury in Emergency Surgery

Recruiting
NCT06812702

Parkinson's Disease Biomarker Study

Completed
NCT04344899

Pediatric Oncology Recovery Trial After Surgery

Completed
NCT05744713

An Observational Study of Patients With Chronic Liver Disease

Enrolling By Invitation
NCT04425434

Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma

Recruiting
NCT04514445

The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.

Recruiting
NCT04425421

Recommendations for the Treatment of Children With Burkitt's Lymphoma

Recruiting
NCT05407480

Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma

Recruiting
NCT02184416

Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting

Completed
NCT03133559

Mapping the Human HIV Chronobiome

Suspended
NCT07409142

BetterLife FSHD: A Patient-driven Health and Research Platform

Recruiting
NCT06651073

ATTR-CM: A Multi-country, Non-interventional Disease Registry

Active Not Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
314